Clinical trial

Study on Human Mass Balance of SPH3127 Tablets

NCT05593562

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-10-16

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2022-10-16Date precision: day

Registry last updated2022-12-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Primary Mild and Moderate Hypertensionunresolved

Interventions

SPH3127DRUG

Sponsors & collaborators

Shanghai Pharmaceuticals Holding Co., Ltdlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05593562 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.